Video

What are the foundational thyroid function laboratory abnormalities that confirm the diagnosis of hypothyroidism; and, once the diagnosis has been made, what are the guideline-directed treatment strategies that should be implemented initially to manage the condition?

What are the foundational thyroid function laboratory abnormalities that confirm the diagnosis of hypothyroidism; and, once the diagnosis has been made, what are the guideline-directed treatment strategies that should be implemented initially ...

Video

Can you summarize what the current evidence, expert opinion, and clinical experience has taught us, and how it should guide us, in terms of identifying persons with hypothyroidism who should be considered for DTE-based hormone replacement therapy?

Can you summarize what the current evidence, expert opinion, and clinical experience has taught us, and how it should guide us, in terms of identifying persons with hypothyroidism who should be considered for DTE-based hormone replacement therapy?

Video

Based on results from North Star as well as other observational trials, what kind of results should clinicians expect when they transition/convert patients from T4 monotherapy to combination therapy with DTE? What percentage of patients can be expected to respond?

Based on results from North Star as well as other observational trials, what kind of results should clinicians expect when they transition/convert patients from T4 monotherapy to combination therapy with DTE? What percentage of patients ...

Video

What are the clinical triggers—among them, lack of symptom control, inability to achieve normalization of thyroid hormone function biomarkers/tests, treatment failure with T4, and metabolic co-morbidities affecting T4-to-T3 conversion—that prompt you to consider a person an ideal candidate for DTE-based hormone replacement?

What are the clinical triggers—among them, lack of symptom control, inability to achieve normalization of thyroid hormone function biomarkers/tests, treatment failure with T4, and metabolic co-morbidities affecting T4-to-T3 conversion—that ...

Video

Once a clinician makes the decision to transition/commit a patient to DTE-based thyroid hormone replacement, what do the trials/studies teach us about the comparative treatment, response rates, patient preferences, and outcomes when T4 monotherapy is compared to DTE?

Once a clinician makes the decision to transition/commit a patient to DTE-based thyroid hormone replacement, what do the trials/studies teach us about the comparative treatment, response rates, patient preferences, and outcomes when T4 ...

Video

Can you highlight some of the most important dimensions of the disease burden associated with hypothyroidism, including decisions related to treatment options and identification of patients who may be refractory to usual therapy?

Can you highlight some of the most important dimensions of the disease burden associated with hypothyroidism, including decisions related to treatment options and identification of patients who may be refractory to usual therapy?

Video

Given your practice focus and experience, can you discuss the disease burden of hypothyroidism, the spectrum of the disease, treatment options, and how DTE formulations differ in terms of T4 and T3 composition?

Given your practice focus and experience, can you discuss the disease burden of hypothyroidism, the spectrum of the disease, treatment options, and how DTE formulations differ in terms of T4 and T3 composition?

Video

Can you summarize your current recommendations and clinical pathway for patient populations who may benefit from DTE? How do you optimize treatment dosing/titration of DTE to achieve the results you are looking for?

Can you summarize your current recommendations and clinical pathway for patient populations who may benefit from DTE? How do you optimize treatment dosing/titration of DTE to achieve the results you are looking for?